Your session is about to expire
← Back to Search
Other
Bone Broth Diet for Weight Loss in Obesity
N/A
Waitlist Available
Led By David Crowley, MD
Research Sponsored by Veyl Ventures LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 22, day 28, day 50, day 56
Awards & highlights
Study Summary
This trial tests how safe and effective a bone broth diet is for weight loss in obese adults. It measures safety, weight, and BMI at two points.
Who is the study for?
Adults aged 35-65 with obesity (BMI between 30.0 and 39.9) who haven't had major surgery recently or plan to during the study, don't smoke, aren't drug/alcohol abusers, have stable weight for the past three months, and are not on medications affecting weight. Women must be non-childbearing or use birth control; men with vasectomy qualify.Check my eligibility
What is being tested?
The trial is testing Dr. Kellyann's Bone Broth Diet to see if it helps obese adults lose weight safely. Participants will follow the diet and their weight loss and BMI changes will be tracked at specific intervals while monitoring for any adverse events.See study design
What are the potential side effects?
Potential side effects may include digestive issues due to dietary changes but specifics aren’t listed in the provided information. Safety will be monitored by recording any adverse events that occur during the trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, day 22, day 28, day 50, day 56
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 22, day 28, day 50, day 56
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The change in body mass index (BMI) from baseline at Days 22 and 50 following the bone broth diet.
The change in weight from baseline at Days 22 and 50 following the bone broth diet.
Secondary outcome measures
The change in android/gynoid fat ratio from baseline at Days 22, 28, and 50 and from Day 28 at Day 50 following the bone broth diet.
The change in arm circumference from baseline at Days 22, 28, and 50 and from Day 28 at Day 50 following the bone broth diet.
The change in blood glucose levels from baseline at Days 22, 28, and 50 and from Day 28 at Day 50 following the bone broth diet.
+17 moreOther outcome measures
Blood pressure (BP) at screening, baseline, day 22, day 28, and day 50 following the bone broth diet.
Creatinine measurement at screening, day 22, and day 50 following the bone broth diet.
Estimated glomerular filtration rate (eGFR) at screening day 22, and day 50 following the bone broth diet.
+26 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Dr. Kellyann's Bone BrothExperimental Treatment1 Intervention
During the bone broth phases, each week will be separated into 'fasting days' and 'feeding days'. There will be 2 non-consecutive fasting days and 5 feeding days per week. On fasting days, participants will be instructed to consume 1 packet of bone broth every 2 hours, for a total of 7 packets/day. On feeding days, participants will consume 3 meals/day, made up of 'Yes' foods portioned according to instructions provided in the Bone Broth Diet Quick Reference Guide and 1 packet of bone broth, twice a day, as snacks between meals. If a bone broth serving is missed participants are instructed to consume the serving as soon as they remember. Participants will be advised not to exceed 7servings of bone broth on fasting days and 2 servings on feeding days. During the maintenance phase, participants will not consume any bone broth.
Find a Location
Who is running the clinical trial?
Veyl Ventures LLCLead Sponsor
KGK Science Inc.Industry Sponsor
78 Previous Clinical Trials
6,060 Total Patients Enrolled
David Crowley, MDPrincipal InvestigatorKGK Science Inc.
35 Previous Clinical Trials
2,653 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been using tobacco products regularly within the past 6 months and plan to continue using them during the study.You have had problems with alcohol or drugs in the past year.Your body mass index (BMI) is between 30 and 39.9, which means you may be overweight or have obesity.You have or had serious problems with your digestive system.You are currently using medical cannabis products.You are allergic, sensitive, or intolerant to any of the ingredients in the experimental medication.You have had a painful episode of gout in the last year.You have obesity caused by medical conditions or hormonal disorders that affect your metabolism, as determined by a specific assessment.You currently have or have had problems with eating, like anorexia or bulimia, as determined by a special questionnaire.You have had gastric bypass surgery or other weight loss surgeries.You have ongoing long-term inflammation in your body, as determined by a medical assessment.You have cancer, except for a type called skin basal cell carcinoma that was removed completely without needing chemotherapy or radiation. If you have been cancer-free for over five years, you can still participate.
Research Study Groups:
This trial has the following groups:- Group 1: Dr. Kellyann's Bone Broth
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger